Welcome to Cryptolife
Curriculum Vitae Of Dr. Su Ih Jen
Experience
2004 - 2006 Consultant, Department of Health, Center for Disease Control
2003 - 2004 Director-General, Center for Disease Control
2001 - 2003 Chief Scientist, Department of Health, Center for Disease Control
2000 - 2002 Professor and Chairman, Department and Institute of Pathology, National Taiwan University Medical College and Hospital
1998 - 2000 Director, Institute of Molecular Medicine and Institute of Clinical Medicine
1995 - 1998 Professor and Chairman, Department of Pathology, National Cheng Kung University Hospital and Medical School, Tainan, Taiwan
1992 - 1993 Visiting Scientist, CRC Laboratory, Department of Cancer Studies (Professor Alan B. Rickinson), University of Birmingham Medical School, Birmingham, England
1991 - 1995 Professor, Department and Institute of Pathology, College of Medicine, National Taiwan University
1988 - 1991 Associate Professor, Department and Institute of Pathology, College of Medicine, National Taiwan University
1987 - 1988 Visiting Assistant Professor, Department of Pathology, Beth Israel Hospital and Harvard Medical School, Boston, MA
1985 - 1988 Instructor and Staff Pathologist, Department of Pathology, college of Medicine, National Taiwan University, Taipei, Taiwan
1983/07 - 1983/09 Visiting Fellow, Surgical Pathology, Department of pathology (Head: Professor Juan Rosai), University of Minnesota, Minneapolis
1982 - 1983 Fellow, Division of Hematopathology, Department of Laboratory Medicine (Director: Professor Marshall E. Kadin), University of Washington Seattle, Washington, USA
1981 - 1985 Staff Pathologist, Department of Pathology, Chang-Gung Memorial Hospital, Taipei, Taiwan
1980 - 1981 Resident, Department of Medicine, Veterans General Hospital, Taipei
1978 - 1980 Resident, Department of Pathology, Tri-service General Hospital, Taipei, Taiwan (Military Service)


Education
1985 - 1988 PhD in Pathology, Institute of Pathology, National Taiwan University, Taipei, Taiwan
1976 - 1978 PhD in Pathology, Institute of Pathology, National Taiwan University, Taipei, Taiwan
1969 - 1976 M.D., College of Medicine, National Taiwan University, Taipei, Taiwan


Research Interests
*Biology and pathology of malignant lymphoma, particularly EBV-associated T cell lymphoma.
*Pathogenesis and mechanism of HBV pre-S mutants and hepatocarcinogenesis.
*Pathogenesis and therapy of virus-associated hemophagocytic syndrome


Publications
1. Lin JK, Su IJ: Inhibition of DNAse I by oxine and folic acid. J Chinese Bioch Soc 1: 89-93, 1972
2. Lin JK, Su IJ, and Hsu SM: Riboflavin-catalyzed photo-degradation of bilirubin. J Formosan Med Assoc 76:293-300, 1977
3. Su IJ, Hsieh BS, Hsu CY, and Lin WSJ: Primary intimal fibroplasia of renal artery. J Formosan Med Assoc 77: 543-547, 1978.
4. Lin TP, Su IJ, Lu SC, and Yang SP: Pulmonary proliferating sparganosis. J Formosan Med Assoc 77: 467-472, 1978.
5. Su IJ: Clinicopathological study of cytomegalovirus infection in autopsy patients. Transaction of the Pathological Society of the Republic of China, 1978 (Master Thesis).
6. Su IJ, Chuang SM,Chu Lin ML, and Lin WSJ: Cytomegalovirus infection in autopsy patients with primary or secondary immunodeficiency. J Formosan Med Assoc 77: 629-639, 1978.
7. Liaw YF, Chu CM, Su IJ, Huang MJ, Lin DY, and Chang-Chien CS: Clinical and histological events preceding hepatitis B e antigen seroconcersion in chronic type B hepatitis. Gastroenterology 84: 216-219, 1983.
8. Shih LY, Su IJ, Wen KW, and Dunn P: Bone marrow involvement in non-Hodgkin's lymphoma. J Formosan Med Assoc 82: 575-581,1983.
9. Su IJ, Kuo T, Wu SY, and Hung IJ: Lymphadenopathic type of Kaposi's sarcoma presenting with generalized petechial hemorrhage. Cancer 54: 984-950, 1984.
10. Kuo T, Su IJ, and Chien CH: Solid and papillary neoplasm of the pancreas. Cancer 54: 1469-1474, 1984.
11. Kadin ME, Nasu K, Sake D, Su IJ: Distinctive phorbol ester induced morphological and surface antigen changes in mycosis fungoides, the Sezary's syndrome, and adult T-cell leukemia. Cancer Res 44: 3383-3387, 1984.
12. Su IJ, Kuo T, Liaw YF: Hepatocyte hepatitis B surface antigen - A useful diagnostic evaluation of patients with clinically acute HBsAg-positive hepatitis. Arch Pathol Lab Med 192: 400-403, 1985.
13. Kuo T, Hsueh S, Su IJ, et al: Histiocytoid hemangioma of the heart with peripheral eosinophilia. Cancer 55: 2854-2861,1985.
14. Su IJ, Kuo T, Chan HL, Eimoto T, Maeda Y, Kikuchi M, Kuan YZ, Shih LY, Chen MJ, and Takeshita M:Adult T-cell Leukemia/lymphoma in Taiwan. A clinicopathological study. Cancer 56: 2217-2220, 1985.
15. Kuo T, Chan JL, Su IJ, Shin LY, Eimoto T: Serological survey of antibodies to adult T-cell leukemia virus-associated antigen (HTLV-A) in Taiwan. Int J Cancer 36: 345-348,1985.
16. Chan HL, Su IJ, Kuo T, et al: Cutaneous manifestations of adult T-cell leukemia/lymphoma. J Am Acad Dermatol 13: 213-219, 1985.
17. Su IJ, Shih LY, Kadin ME, Dunn P, and Hsu SM: Pathological and immunological characterization of malignant lymphoma in Taiwan. Am J Clin Pathol 84: 273-280, 1985.
18. Su IJ, Chen WJ: High frequency of transitional cell cerinoma of the urinary tract in an endemic area of chronic arse-nicism. J Chinese Oncol Soc 1(4): 29-36, 1985.
19. Tien HF, Wang CH, Yang CS, Su IJ, Chen YC, Shen MC, Liu CH: Mixed megakaryoblastic and myeloblastic leukemia in patients with acute phase of chronic myelogenous leukemia . J Formosan Med Assoc 85: 963-972, 1986.
20. Su IJ, Lai MY, Hsu HC, Chen DS, Yang PM, Chuang SM, Sung JL: Diverse Virologic, histopathologic, and prognostic implications of seroconversion form hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection. J Hepatology 3: 82-189, 1986.
21. Hsu HC, Wu MZ, Chang MH, Su IJ, Chen DS: Childhood hepatocellular carcinoma develops exclusively in HBV carriers in three decades in Taiwan. J Hepatol 1987;5:260-267
22. Hsu HC, Su IJ, Lai MY, Chen DS, Chang MH, Chuang SM, Sung JL: Biologic and prognostic significance of hepatocyte hepatitis B core antigen expressions in the natural course of chronic hepatitis B virus infection. J Hepatol 5: 45-50,1987.
23. Wu CT, Hsu HC, Chen DS, Sheu JC, Su IJ, Chen SL, Chuang SM: Clearance of hepatitis B surface antigen (HBsAg) after surgical resection of hepatocellular carcinoma. J Hepatol. 4: 45-51, 1987.
24. Chen DS, Su IJ, Lai MY, Hsu HC, Yang PM, Sheu JC, Sung JL: Delta agent infection in Taiwan. J Gastroenterology and Hepatology 2: 1-8, 1987.
25. Hsu HC, Lin YH, Chand NH, Su IJ, Chen DS: Pathology of chronic Hepatits B virus infection in children: with special reference to the intrahepatic expression of hepatitis B virus antigens. Hepatology 8: 378-382, 1988
26. Shih LY, Su IJ: Chronic myeloid leukemia: Manifesting as spontaneous splenic rupture and terminating in megakaryocytic transformation. Medical and Pediatric Oncology. 15: 31-37, 1987.
27. Yang PM, Chen DS, Lai MY, Su IJ, Huang GT, Lin JT, Sheu JC, Hsu HC, Sung JL: Clinicopathologic studies of asymptomatic HBsAg carriers: with special emphasis on carriers older than 40 years. Hepato-Gastroenterology 34: 251-254, 1987.
28. Lai MY, Chen Ds, Lee SC, Su IJ, Yang PM, Hsu HC, Sung JL: Reactivation of hepatitis B virus in anti-HBe-positive chronic active type B hepatitis: molecular and immunohisto-chemical studies. Hepato-Gastroenterol 35: 17-21, 1988.
29. Su IJ, Wang CH, Cheng AL, Chen YC, Hsieh HC, Chen CL, et al: Characterization of the spectrum of postthymic T-cell malignancies in Taiwan - A clinicopathological study of HTLV-1-positive and negative cases. Cancer 61: 2060-2070, 1988.
30. Su IJ, Balk S, Kanin ME: Molecular basis for the aberrant expression of T-cell antigens in postthymic T-cell malignancies. Am J Pathol 132: 192-198, 1988.
31. Su IJ: Pathologic studies of malignant lymphomas in Taiwan-with emphasis on the pathologic spectrum, possible etiology and biologic behaviors of T-cell malignancies. Ph.D. dissertation, Institute of Pathology, National Taiwan University, 1988
(Advisor: Professor Sou-Ming Chuang, M.D.)
32. Hsu HC, Lai MY, Su IJ, Chen kDS, Hsieh HC: Correlation of hepatocyte HBsAg expression with virus replication and liver pathology. Hepatology 8: 749-755, 1988.
33. Yang PM, Su IJ, Lai MY, Huang GY, Hsu HC, Correlation of hepatocyte HBsAg expression with virus replication and liver pathology. Hepatology 8: 749-755, 1988.
34. Su IJ, Kadin ME: Expression of growth factor/receptor genes in postthymic T-cell malignancies. Am J Pathol 135: 439-445, 1989.
35. Cheng AL, Chen YC, Su IJ, Wang CH, Hsieh HC, Chen CL, Lai HS, Liu TW, Tien HF, Shen MC, Liu CH: Adult non-Hodgkin's lymphoma in Taiwan areas -- A clinico-pathological study of 123 cases based on working Formulation classification. J Formosan Med Assoc 88: 114-121, 1989.
36. Cheng AL, Chen YC, Wang CH, Su IJ, HC, Chang JY, Hwang WS,Su WC, Liu TW, Tien-HF, Tsai W, Shen MC, Liu CH: Direct comparisons of peripheral T cell lymphoma with diffuse B cell lymphoma of comparable histological grades - Is PTCL a unique entity of lymphoma which warrants separate consideration. J Clin Oncol 7: 715-723, 1989.
37. Chen YC, Wang CH, Su IJ, Hu CY, Chou MJ, Lee TH, Lin DT, Chung TY, Liu CH, Yang CS: Infection of human T-cell Leukemia virus type I and development of human T cell leukemia/lymphoma in patients with hematological neoplasms – A possible linkage to blood transfusion. Blood 74: 388-394,1989.
38. Su IJ, Hsieh HJ, Lee CY: Histiocytic medullary reticulosis: A lethal form of primary EBV infection in young children in Taiwan. Lancet 1: 389, 1989.
39. Lee HS, Yang PM, Liu BF, Lee CL, Hsu HC, Su IJ, Chen DS: Pleural effusion coinciding with acute exacerbations in a patient with chronic hepatitis B. Gastroenterology 96: 1604-1606, 1989.
40. Tien HF, Wang CH, Su IJ, Liu Fs, Wu HS, Chen YC, et al: A subset of acute nonlymphocytic leukemia with expression of surface antigen CD7-Morphologic, cytochemical, and clinical studies. Leukemia Res 14: 515-523, 1990.
41. Su IJ, Wu EC, Chen YC, Cheng AL, Wang CH, Kadin ME: Cutaneous manifestation of post-thymic T cell malignancies: Description of 5 clinicopathologic subtypes. J Am Acad. Dermatol 18: 653-662, 1990.
42. Su IJ, Hsieh HC, Lin TC, et al: Fatal primary Epstein-Barrvirus infection masquerading as histiocytic medullary reticulosis. Hematol Pathol 4(4): 189-195, 1990.
43. Su IJ, Lin KS, Hsieh HC, et al: Epstein-Barr virus-associated T cell lymphoma of activated CD8 phenotype. Cancer 66: 2557-2563, 1990.
44. Su IJ, Hsieh HC, Wang CI, Chang IC, Chen CY: Southern blot-detection of HTLV-1 and EBV DNA in lymphoma tissues - An analysis of 156 cases. J Chinese Oncology Society 6 (3): 1-10, 1990.
45. Lee SH, Su IJ, Chen JR, et al: A study of childhood lymphoma in Taiwan: with special reference to peripheral T cell lymphoma and the association with Epstein-Barr viral infection. Cancer 1991; 96: 171-176.
46. Chen JR, Su IJ, Lee SH, et al: Fatal hemophagocytic syndrome in Taiwan - An atypical form of infectious mononucleosis. Am J Clin Pathol 1991; 96: 171-176.
47. Su IJ, Hsieh HC, Cheng AL, Cheng JY: Aggressive peripheral T cell lymphoma containing Epstein-Barr viral DNA: A clinicopathologic and virologic analyses. Blood 77: 799-808, 1991.
48. Chou CM, Cheng AL, Su IJ, Wang CH: Retinoid acid in the treatment of cutaneous Ki-1 large cell lymphoma. Cancer 1991; 67: 2490-2494.
49. Su IJ, Chang IC, Cheng AL: Expression of growth-related genes and drug resistance genes in HTLV-1-positive and HTLV-1-negative post-thymic T cell malignancies. Annal of Oncology 1991; 2 (suppl 2): 151-155.
50. Chun WM, Tien HF, Lin DT, Lin KH, Su IJ, Chen BW, Lin KS, Liang DC: Infant leukemia: an analysis of nine Chinese patients. Am J Hematol 34: 246-251, 1991.
51. Chen CM, Chao K, Su IJ: Acute primary Epstein-Barr virus infection presenting as acute abdomen. Ped. Inf. Dis. J. 1991; 10: 471-473.
52. .Tien HF, Wang CH, Su IJ, Wu HS, Chien SH, Chen YC, Lin DT, Lin KS, Shen MC: Immunoglobulin and T-cell receptor gene rearrangement in acute lymphoblastic leukemic -A higher incidence of double rearrangements in patients with myeloid antigen expression. Leukemia Res. 1991; 15: 91-98.
53. Lin MT, Shen MC, Su IJ, et al: Peripheral Tr/d lymphoma presenting with idiopathic thrombocytopenic purpura-like picture. Br. J. Hematol 1991; 78: 280-282.
54. Tsai TF, Su IJ, Hsieh HC, Cheng AL, Uen WC, Lii YC: Epstein-Barr virus associated angiocentric cutaneous T cell lymphoma. J Am Acad Dermatol 1992; 26: 31-38.
55. Cheng AL, Su IJ: Peripheral T cell lymphoma and adult T cell lymphoma. In: Carbone P, and Brain M. (eds). Current Therapy in Hematology-Oncology. B.C. Decker, pp. 360-364, 1992.
56. Hung JL, Su IJ, Chen YC, Wang CH: Hodgkin's disease and non-Hodgkin's lymphoma containing RS cells: A study of 54 cases. Cancer 1992; 69: 1254-1258.
57. Su IJ, Hsieh HC (Review Article): Clinicopathologic spectrum of Epstein-Barr virus-associated T cell malignancies. Leukemia and Lymphoma 1992; 7: 47-53.
58. Cheng AL, Su IJ, Chang IC: Expression of P-glycopretein and glutathione-s-transferase I1 in relapsing lymphoma -Correlation of immunophenotype and EBV association. J Clin. Oncol. 1993; 11: 109-115.
59. Tien HF, Su IJ, Chuang SM, et al: Cytogenetic characterization of Epstein-Barr virus-associated T cell malignancies. Cancer Genetics and Cytogenetics 1993; 69: 25-30
60. Su IJ, Tsai TF, Cheng AL, Wang CH: Cutaneous manifestions of Epstein-Barr virus-associated T cell malignancies. J Am Acad Dermatol 1993; 29: 685-692
61. Su IJ (editor):Book on the Etiology, Diagnosis and Treatment of Malignant Lymphoma, United Press, Taipei, 1993.
62. Tsai TF, Chen RL, Su IJ, et al: Epstein-Barr virus-associated cutaneous large granular lymphoproliferation presenting as vasculitis. J Am Acad Dermatol 1994; 30: 756-759
63. Su IJ, Hsu YH, Wang CH: T cell lymphoma associated with Epstein-Barr virus and hemophagocytosis mimicking malignant histiocytosis. Cancer 1993; 72: 909-916
64. Cheng AL, Su IJ, Chen YC, Ven WC, Wang CH: Characteristic clinicopathologic features of EBV-associated peripheral T cell lymphoma. Cancer 1993; 72: 909-916
65. Cheng AL, Su IJ, Chen YC, Lee TC, Wang CH: Expression of P-glycoprotein and glutathionl-S-transferase in recurrent lymphomas: the possible role of Epstein-Barr virus immunophenotypes, and other predisposing factors. J Clin Oncol 1993; 11: 109-115
66. Chen CL, Sadler RH, Walling DM, Su IJ, Hsieh HC, Raab -Traub N:Epstein-Barr Virus (EBV) gene expression in EBV-positive peripheral T cell lymphomas. J. Virol 1993; 67: 6303-6308
67. Su IJ, Cheng AL, Lay TD: Retinoic acid-induced apoptosis and regression of a refractory Epstein-Barr virus-containing T cell lymphoma expressing multidrug resistance phenotype. Br. J. Hematol 1993; 85: 826-828
68. Liaw YS, Yang P.C, Su IJ, Kuo SH, et al: Mucosa-associated lymphoid tissul lymphoma of the lung with cold-reacting autoantibody-mediated hemolytic anemia. Chest 1994; 105: 288-290
69. Cheng AL, Su IJ, Tien HF, et al: Characteristic clinicopatholagic features of adult B-cell lymphoblastic lymphoma with special emphasis on differential diagnosis with an atypical form probably of lymphoblastic lymphocytic lymphoma of intermediate differentiation origin. Cancer.1994; 73: 706-710
70. Su IJ, Cheng JR, Lin KH, Lin DT, chen TT: Epstein-Barrvirus primarily infects T lymphocytes in childhood EBV-associated hemophagocytic syndrome. Am J Pathol 1994; 144: 1219-1225
71. Su IJ, Lay JD, Cheng AL, Kadin ME: Modulation of retinoic acid receptor-α, protooncogenes, and transforming growth factor genes in RA-responsive Ki-1 lymphoma. Int. J. Oncol. 1994; 4: 1089-1095
72. Ming Yao, Su IJ (Corresponding author), Chen AL, et al: Clinicopathologic spectrum of hemophagocytic syndrome in EBV-associated T cell lymphoma. Br.J. Hematol 1994; 87: 535-543
73. Cheng AL, Su IJ, Chen CC, Lay JD, et al: Use of retinoids in the treatment of peripheral T cell lymphoma-A pilot study. J. Clin. Oncol. 1994; 12: 1185-1192
74. Lin KH, Su IJ, Chen RL, etal: Peripheral T-cell Lymphoma in childhood: A report of five cases in Taiwan. Med. And Pediatric Oncology 1994; 23: 26-35
75. Chang CS, Wang CH, Su IJ, et al: Hematophagic histiocytosis:A Chinicopathologic analysis of 23 cases with special reference to the association with peripheral T-cell lymphoma.J. Formosan Med. Assoc. 1994; 93: 421-42
76. Chen JR, Su IJ (Corresponding author), Lin KH, Lin DT, et al: Immunomodulation treatment of childhood lymphohistiocytic hemophagocytosis. British Journal of Hematology 1995; 89: 282-290.
77. Su IJ, Hsu YH, Chang YC,Wang IW: Herpesviruslike DNA sequence in Kaposi's sarcoma from AIDS and non-AIDS patients in Taiwan. Lancet 1995; 345: 722-723
78. Su IJ ( letter ) : Etoposide (VP-16) inhibits Epstein-Barr virus determined nuclear antigen (EBNA) synthesis. Br. J. Hematol 1995; 90: 971-973
79. Pu YS, Hsieh TS, Tsai TC, Cheng AL, Hsieh CY, Su IJ, Lai MK: Tamoxifen enhances the chemosensitivity of bladder carcinoma cells. J.Urol 1995: 154; 601-605
80. Wang CC, Tien HF, Lin MT, Su IJ, Wang CH, Chuang SM: Consistent presence of isochromosome 7q in hepatosplenic T gamma/delta lymphoma: a new cytogenetic-clinicopathologic entity. Gene Chromosome Cancer 1995; 12: 161-164
81. Su IJ, Wang CH, Chen RL: Clinicopathologic spectrumHemophagocytic syndrome in Epstein-Barr virus-associated T-lymphoproliferative disorders: disease spectrum, pathogenesis, and management. (Review Article). Leukemia and Lymphoma 1995; 19: 401~406.
82. Yao M, Tien HF, Wang CH, Su IJ, Chen YC, Sheng MC: Clinical and hematologic features of T gamma/delta lymphoma. Leukemia and Lymphoma 1995; 19: 518~523.
83. Chang YS, Su IJ, Chung PJ, Shu CH, Ng CK, Wu SJ, Liu ST: Detection of an Epstein-Barr virus variant in T-cell lymphoma tissues identical to the distinct strain observed in nasopharyngeal carcinoma in the Taiwanese population. Int J Cancer 1995; 62:673~677.
84. Jaffe E, Chan JK, Su IJ, Frizema G. Ho F: Angiocentric nasal and extra-nasal T/NK cell lymphoma: Summary of Clinical features, definition and prognosis. Am J Surg Pathol 1996; 20: 103~111.
85. YM Teng, Tien HF, Su IJ: Phenytoin-induced pseudolymphoma: Re-evaluation with modern molecular biology technique. Epilepsia 1996; 37: 104~107.
86. Su IJ, Huang LM, Tsai TF, et al: Detection and sequence analysis of herpesvirus-like DNA sequence in AIDS- and non-AIDS KS in Taiwan: A comparison with related herpes viruses. J Formosan Med Assoc 1996; 95: 13~18.
87. Chen HW, Fong L, Su IJ, Ting LL, Hong RL, Leung WC, Lui LT: Experience of radiotherapy in lethal midline granuloma with special emphasis on centrofacial T cell lymphoma. Radiotherapy and Oncology 1996; 38:1~6.
88. Jin YT, Tsai ST, Yan JJ, Hsiao JH, Lee YY, Su IJ: Detection of Kaposi's sarcoma(KS)-associated herpesvirus-like DNA sequence(KSHV) in vascular lesions: A reliable diagnostic marker for KS. Am J Clin Pathol 1996; 105:360~363
89. Hsiao JH, Lee WY, Chang SJ, Su IJ : Angiocentric T cell lymphoma of the intestine: A distinct etiology of ischemic bowel disease. Gastroenterology 1996; 110: 985~990.
90. Jin YT, Tsai ST, Su IJ: Expression of EBV genomes (EBER1) in nasopharyngeal carcinoma: A comparison with WHO histologic subtypes. Cancer 1996; 77: 231~236.
91. Jin YT, Tsai ST, Su IJ: Presence of a Herpesvirus-like DNA sequence in oral Kaposi's sarcoma and other neoplasms. Oral Surgery, Oral Medicine, Oral Pathology Oral Radiol Endod 1996; 81: 442~444.
92. Su IJ: Epstein-Barr Virus and T cell Lymphoma. Epstein-Barr Virus Report 1996; 4: 1~10.
93. Pu YS, Hsieh TS, Cheng AL, Tseng NF, Su IJ. Hsieh CY, Lai MK, Tsai TC:Combined cytotoxic effects of tamoxifen and chemtherapeutic agents on bladder cancer cells. Br. J. Urol 1996; 77: 76~85.
94. Chou KS, Okayama A, Su IJ, Lee TH, Essex M: Preferred nucleotide sequence at the integration site of HTLV-1 from patients with adult T-cell leukemia. Int. J. Cancer 1996; 65: 20~24
95. Pu YS, Tsai TC, Cheng AL, Tsai CY, Tseng NF, Su IJ, Hsich CY, Lai MK:Expression of MDR-1 gene in transitional cell carcinoma and its correlation with chemotherapy response. J Urol 1996; 156: 271~275.
96. Lu JY, Chen JY, Hsu TY, Yu CY, Su IJ, Yang CS: Induction of apoptosis in epithelial cells by Epstein-Barr virus latent membrane protein 1. J General Virol 1996; 77: 1883~1892.
97. Jaffe E, Chan JK, Su IJ, Frizema G. Ho F: Angiocentric nasal and extra-nasal T/NK cell lymphoma: Summary of Clinical features, definition and prognosis. Am J Surg Pathol 1996; 20: 103~111.
98. Chiang IP, Cheng AL, Lin JT, Su IJ : Low grade mucosa-associated lymphoid tissue type lymphoma (MAL Toma) of the stomach: A pathologic analysis of 19 cases. J Formasan Med Assoc 1996; 95:857~865.
99. Chen HL, Huang LM, Lee PI, Su IJ, Lin KH, Lee CY: Late transition from infectious mononucleosis with encephalitis to fatal hemophagocytic syndrome. Int. J. Pediatric Hematol/Oncol 1996; 13: 195~200.
100. Wu SJ, Lay JD, Chen CL, Chen JY, Liu MY, Su IJ: Genomic analysis of Epstein-Barr virus in nasal and peripheral T cell lymphoma. J Med Virol 1996; 50: 314~321.
101. Chou WC, Su IJ, Tien WF, Liang DC, Wang CH, Chang YC, Cheng AL: Clinicopathologic, cytogenetic, and molecular studies of 13 Chinese patients with Ki-1 anaplastic large cell lymphoma. Cancer 1996; 78: 1805~1812.
102. Chen FF, Yan JJ, Jin YT, Su IJ: Detection of bcl-2 and p53 in thymoma: expression of bcl-2 as a reliable marker of tumor aggressiveness. Hum Pathol 1996; 27: 1089~1092.
103. Liu MY, Chen KC, Su IJ, Hsu MM, Chen CY, Yang CS: Sequence analysis of Epstein-Barr virus(EBV) Bam HIF DNA fragment in EBV-associated diseases. J Med Virol 1996; 50: 314~321.
104. Chow NH, Guo YL, Lin SN, Su HJ, Tzai TS, Guo HR, Su IJ : Clinicopathologic features of bladder cancer associated with chronic exposure to arsenic. Br. J. Cancer 1997; 75:1708~1710.
105. Su IJ, Chen JY: The role of Epstein-Barr virus in lymphoid malignancies. Critical Review in Oncology/Hematology 1997; 26: 25~41.
106. Jin YT, Tsai ST, Li C, Chang KC, Yan JJ, Chao WY, Eng HL, Chou TY, Wu TC, Su IJ: Prevalence of human papillomavirus in middle ear carcinoma associated with chronic otitis media. Am J Pathol 1997; 150: 1327~1333.
107. Tsai ST, Li C, Jin YT, Chao WY, Su IJ: High prevalence of human papillomavirus Type 16 and 18 in middle ear carcinomas. Int J. Cancer 1997; 71:208~212.
108. Chow NH, Liu HS, Yang HB, Chan SH, Su IJ: Expression patterns of erbB receptor family in normal urothelium and transitional cell carcinoma. Virchows Arch 1997;430:461-466
109. Chang HJ, Su IJ, Chen CL, Chiang IP, Chen YC, Wang CH, Chang AL: Angioimmunoblastic lymphadeno-pathy with dysproteinemia—Lack of a prognostic value of clear cell morphology. Oncology 1997; 54: 193~198.
110. Tien HF, Su IJ, Tan JL, Liu MC, Lee FY, Chen YC: Clonal chromosomal abnormalities as direct evidence for clonality in nasal T/NK cell lymphomas. Br. J. Hematol 1997; 97: 621~625.
111. Flaitz CM, Jin YT, Hicks MJ, Nichols CM, Wang YW, Su IJ: Kaposi’s sarcoma-associated herpes-like DNA sequences ( KSHV/HHV-8 ) in oralAIDS-Kaposi’s sarcoma—A PCR and clinicopathologic study. Oral Surgery Oral Med Oral Pathol Oral Radiol Endod 1997;83:259-264
112. Chen JS, Tszen CC, Tsao CJ, Chen TY, Su IJ: Clonal karyotype abnormalities in EBV-associated hemophagocytic syndrome. Hematologica 1997;82:572-576
113. Lay JD, Csao TJ, Chen JY, Kadin ME, Su IJ ( correspondence ): Upregulation of tumor necrosis factor-alpha by EBV and activation of macrophages in EBV-infected T cells in the pathogenesis of hemophagocytic syndrome. J Clin Invest 1997; 100:1969-1979
114. Lu TJ, Lu TL, Su IJ, Lai MT: Tyrosine kinase expression profile in bladder cancer. Anti-cancer Research 1997;17:2635-2638
115. Lu JY, Chen JY, Hsu TY, Yu CY, Su IJ, Yang CS: Cooperative interaction between bcl-2 and Epstein-Barr virus latent membrane protein 1 in the growth transformation of human epithelial cells. J Gen Virol 1997;78:2975-2985
116. Cheng AL, Chuang SE, Su IJ: Factors associated with the therapeutic efficacy of retinoic acids on malignant lymphomas. J Formos Med Assoc 1997;96:525-534
117. Yan TJ, Chen FF, Jin YT, WuCC, Su IJ: Differentiation of BCG-induced lymphadenitis from tuberculosis in lymph node biopsy specimens by molecular analysis of pcnA and oxyR. Journal of Pathology 1998;184:96-102
118. Chen JH, Lin KS, Chen RL, Lin DT, Su IJ: Longitudinal observation and outcome of non-familial hemophagocytic syndrome receiving etoposide-containing regimen. Br. J. Hematol 1998;103:756-762
119. Lee PC, Wang YW, Su IJ, Lin DY, Lei HY: Immunosuppressive drugs and Kaposi’s sarcoma virus ( HHV-8 ) in a renal transplantant with Kaposi’s sarcoma. Lancet 1998;1:192-193
120. Chen FF, Yan JJ, Lai WW, Jin YT, Su IJ: Epstein-Barr virus-associated non-small cell carcinoma—Undifferentiated “lymphoepithelioma-like” carcinoma as a distinct entity with better prognosis. Cancer 1998;82:2334-2342
121. Liu HS, Lee CH, Lee CF, Su IJ, Chang TY: Lac/Tet Dual-Inducible system functions in mammalian cell lines. Biotechniques 1998;24:624-632
122. Tsai ST, Jin YT, Leung WC, Wang ST, Tsao CJ, Su IJ: Bcl-2 and PCNA expression correlates with subsequent local recurrence in nasopharyngeal carcinoma. Anti-Cancer Research 1998;18:2849-2854
123. Lee WY, Jin YT, Chang TW, Su IJ : Immunolocalization of BRCA1 protein in normal breast tissue and sporadic invasive ductal carcinoma: A correlation with other biologic parameters. Histopathology 1999;34:106-112
124. Hsiao CH, Su IJ, Hsieh SW, Huang SF, Tsai TF, Chen MY, How SW: Epstein-Barr virus-associated intravascular lymphomatosus within Kaposi’s sarcoma in an AIDS patient. Am J Surg Pathol 1999;23:482-487
125. Zong JC, Ciufo DM, Alcendor DJ, Wang XY, Nicholas J, Su IJ, Powell KF, Croxson M, Hayward G: High level variability in the ORF-K1 protein gene at the left end of KSHV genome defines four major subtypes and multiple variants or clades in different human populations. J Virol 1999;73:4156-4170
126. Sheu BS, Yang HB, Wu JJ, Huang AH, Lin XZ, Su IJ: Deveolpment of Helicobacter pylori infection model in BALB/c mice with domestic cagA-positive and –negative strains in Taiwan. Digestive Disease and Science 1999;44:868-875
127. Lo CY, Yang YJ, Su IJ: Abdominal aortic aneurysm associated with Epstein-Barr virus-positive T cell lymphoma. Human Pathol 1999; 50:456-461
128. Su IJ, Hsiao CH ( letter ): Epstein-Barr virus-related intravascular ymphomatosis. Am J Surg Pathol 2000;24:309-310
129. Fan YF, Lu CC, Vhang YC, Chang TT, Lin PW, Lei HY, Su IJ : Identification of a pre-S2 mutant in hepatocytes expressing a novel marginal pattern of surface antigen in advanced diseases of chronic hepatitis B virus infection. J Gastroenterol and Hepatol 2000;15:519-5282
130. Wang KC, Cheng AL, Chuang SE, Su IJ: Retinoic acid-induced apoptotic pathway in T cell lymphoma: Identification of four groups of genes with differential biologic function. Experimental Hematology 2000; 28:1441-1450
131. Yan JJ, Wang JR, Liu CC, Yang HB, Su IJ: An outbreak of enterovirus 71 infection in Taiwan 1998: a comprehensive pathological, virological, and molecular study on a case of fulminant encephalitis. J Clin Virol 2000;17:13-22
132. Wang JR, Tsai HP, Chen PF, Lai YJ, Yan JJ, Kiang D, Lin KH, Liu CC, Su IJ: An outbreak of entervirus 71 infection in Taiwan, 1998. II. Laboratory diagnosis and genetic analysis. J Clin Virol 2000;17:91-99
133. Yu CK, Chen CC, Chen CL, Wang JR, Liu CC, Yan JJ, Su IJ: Neutralizing antibody provided protection against enterovirus Type 71 lethal challenge in neonatal mice. Journal of Biomedical Science 2000;7:523-528
134. Chen JS, Chang KC, Cheng CN, Tsai WH, Su IJ: Childhood hemophagocytic syndrome associated with Kikuchi’s disease. Hematologica 2000;85:998-1000
135. Yan JJ, Su IJ, Chen PF, Liu CC, Yu CK, Wang JR: Complete genome analysis of of EV 71 isolated from an ourbreak in Taiwan and rapid identification of EV 71 and Coxsackievirus A16 by RT-PCR. J Med Virol 2001;65:331-339
136. Fan YF, Lu CC, Chen WC, Wang HC, Hsiao AL, Lei HY, Su IJ: Prevalence and significance of pre-S mutants in serum and liver at different replicative stages of chronic HBV infection. Hepatology 2001;33:277-286
137. Chang KJ, Jin YT, Su IJ : Follicular dendritic cell sarcoma of colon mimicking stromal tumor. Histopathology 2001;38:25-29
138. Hsu YH, Kao JH, Su IJ : Clinicopathologic studies of Kaposi’s sarcoma and strain analysis of KSHV/HHV-8 in eastern Taiwan-Hua-lien area. J Formosan Med Assoc 2001;449-454
139. Chen LC, Lin CT, Shyu RY, Jan CH, Chen CL, Chiang IP, Liu SM, Su IJ, Cheng AL: Prospective study of H. pylori eradication therapy in stage IE high grade mucosa-associated lymphoid tissue lymphoma of the stomach. J Clin Oncol 2001;19:4245-4251
140. Pileri SA, Grogan TM, Harris NL, …, Su IJ, Warnke RA, and Wesiss LM : Tumours of histiocytes and accessory dendritic cells : an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology 2002, 41, 1-29
141. Wang JR, Tuan YC, Tsai HP, Yan JJ, Liu CC, and Su IJ: Change of major genotype of EV 71 in outbreaks of hand-foot-and mouth disease in Taiwan between 1998 and 2000. J Clin Microbiol. 2002;40:10-15
142. Wang YF, Lee SB, Cheng CW, Tai MH, Su IJ: Detection of serum antibodies to three different recombinant antigens of human herpesvirus 8 by immunoblotting: seroprevalence studies in Taiwan. Clinica Chimica Acta 2002;320:37-42
143. Yang YC, Hsu TY, Lin RH, Su IJ, Chen JY, Yang CS: Resistance to tumor necrosis factor-alpha-induced apoptosis in human HTLV-1-infected T cell lines. AIDS Res Human Retroviruses 2002;18(3):207-212
144. Chang KC, Su IJ, Jin YT: Pathologic features of betel-quid-related oral epithelial lesions in Taiwan with special emphasis on the tumor progression and HPV association. Oncology 2002;63:362-369
145. Huang CL, Lin ZZ, Su IJ, Chao TY, Tien HF, Chang MC, Cheng AL: Combination of 13-cis0retinoic acid in the treatment of recurrent or refractory peripheral T cell lymphoma. Leukemia and lymphoma 2002;43(7):1415-1420
146. Hsiao CH, Kao HL, Lin MC, Su IJ: Ulcerative colon T-cell lymphoma: an unusual entity mimicking Crohn's disease and may be associated with fulminant hemophagocytosis. Hepato-gastroenterology. 2002;49(46):950-4.
147. Lay JD, Chuang SE, Rowe M, Su IJ: Epstein-Barr Virus latent membrane protein-1 mediates upregulation of tumor necrosis factor-alpha in EBV-infected T cells: implications for the pathogenesis of hemophagocytic syndrome. J Biomed Sci. 2003;10(1):146-55.
148. Cheng AL, Hsiung CA, Su IJ, Chen PJ, Chang MC, Tsao CJ, et al: Ssteroid-free chemotherapy in the treatment of HBV carriers with lymphoma. Hepatology, 2003; 37(6):1320-8
149. Wang JT, Sheeng TS, Su IJ, Chen JY, Chen MR: EBNA-1 sequence variations reflect active EBV replication and diseases status or quiescent latency in lymphocytes. J Med Virol 2003;69:417-425
150. Sun H., Su IJ, Lin YC, Chen JS, and Fang SY : A 2.6 Mb interval on chromosome 6q25.2-q25.3 is commonly deleted in human nasal natural killer/T-cell lymphoma. British Journal of Hematology , 2003,122,590-599
151. Wang SM, Lei HY, Huang KJ, Wu JM, Wang JR, Yu CK, Su IJ, Liu CC: Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema. J Infect Dis. 2003 Aug 15;188(4):564-70.
152. Lee ML, Chen CJ, Su IJ, Chen KT, Yeh CC et al. Use of Quarantine to Prevent Transmission of Severe Acute Respiratory Syndrome---Taiwan, 2003. Morbidity and Mortality Weekly Report ( MMWR ), Centers for Disease Control and Prevention. July 25, 2003/52(29);680-683
153. Wang HC, Wu HC, Chen CF, Fausto Nelson, Lei HY, Su IJ : Different Types of Ground Glass Hepatocytes in Chronic Hepatitis B Virus Infection Contain Specific Pre-S Mutants that May Induce Endoplasmic Reticulum Stress. American Journal of Pathology. 2003;163:2441-2449
154. Jiang SS, Chen TC, Yang JY, Hsiung CA, Su IJ, Liu YL, Chen PC and Juang JL: Sensitive and Quantitative Detection of Severe Acute Respiratory Syndrome Coronavirus Infection by Real-Time Nested Polymerase Chain Reaction. Clinical Infectious Diseases 2004:38 :293-6
155. Chang WW, Su IJ, Lai MD, Chang WT, Huang WY, Lei HY: The role of inducible nitric oxide synthase in a murine acute hepatitis B virus (HBV) infection model induced by hydrodynamics-based in vivo transfection of HBV-DNA. Journal of Hepatology 2003 ;39:834-842.
156. Chen YC, Yu CK, Wang YF, Liu CC, Su IJ and Lei HY: A murine oral enterovirus 71 infection model with central nervous system involvement. Journal of General Virology. 2004;85:69-77
157. Wu HS, Chiu SC, Tseng TC, Lin SF, Lin JH, Hsu YF, Wang MC, Lin TL, Yang WZ, Ferng TL, Huang KH, Hsu LC, Lee LL, Yang JY, Chen HY, Su SP, Yang SY, Lin TH, Su IJ: Serologic and molecular biologic methods for SARS-associated coronaviurs infection, Taiwan. Emerg Infect Dis. 2004;10:304-310.
158. Yeh SH, Wang HY, Tsai CY, Kao CL, Yang JY, Liu HW, Su IJ, Tsai SF, Chen DS, Chen PJ: National Taiwan University SARS Research Team. Characterization of severe acute respiratory syndrome coronavirus genomes in Taiwan: molecular epidemiology and genome evolution. P N A S (USA). 2004 : 24;101(8):2542-7.
159. Li CC, Tien HF, Tang JL, Yao M, Chen YC, Su IJ, Hsu SM, Hong RL: Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/T-cell or T-cell lymphoma. Cancer. 2004;100(2):366-75.
160. Kaydos-Daniels SC, Olowokure B, Chang HJ, Barwick RS, Deng JF, Lee ML, Kuo SH, Su IJ, Chen KT, Maloney SE and SARS International Field Team. Body temperature monitoring and SARS fever hotline, Taiwan. Emerg Infect Dis. 2004;10(2):373-6.
161. L. Clifford McDonald, Andrew E. Simor, Su IJ, Susan Maloney, Marianna Ofner, Kow-Tong Chen, James F. Lando, Allison McGeer, Min-Ling Lee, Daniel B. Jernigan. SARS in Healthcare Facilities, Toronto and Taiwan. Emerg Infect Dis. 2004;10(5):777-781
162. Wu HS, Hsieh YC, Su IJ, Lin TH, Chiu SC, Hsu YF, Lin JH, Wang MC, Chen JY, Hsiao PW, Chang GD, Wang Andrew HJ, Ting HW, Chou CM, and Hwang CJ. Early detection of antibodies against various structural proteins of the SARS-associated coronavirus in SARS patients. J Biomed Sci.2004; 11:117-126.
163. Chang KC , Huang GC , Jones Dan , Tsao CJ , LeeJY , Su IJ . Distribution and Prognosis of WHO Lymphoma Subtypes in Taiwan Reveals a Low Incidence of GerminalCenter-DerivedTumors.Leukemia&Lymphoma 2004;45(7):1375-1384.
164. Chen CY , Yao M , Tang JL , Tsay W , Wang CC , Chou WC , Su IJ , Lee FY , Liu MC , Tien HF . Chromosomal abnormalities of 200 Chinese patients with non-Hodgkin`s lymphoma in Taiwan : with special reference to T-cell lymphoma. Annals of Oncology , 2004, 1091-1096 2
165. Ho MH, Su IJ: Preparing to prevent severe acute respiratory syndrome and other respiratory infections. Lancet Infectious Disease 2004;4:684-89
166. Hsieh YH, Su IJ, Wang HC, Chang WW, Lei HY, Lai MD, Chang WT, Huang WY: Pre-S mutant surface antigens in chronic HBV infection induce oxidative stress and DNA damage. Carcinogenesis 2004;25:2023-2032
167. Chang LY, Huang YH, Wu YC, Su IJ, Chiu NC, Chen KT, Wu HS, Lin TH, Peng SF, Kao CL, Lee CY, Huang LM: Childhood severe acute respiratory syndrome in Taiwan and how to differentiate it from childhood influenza infection. Arch Pediatr Adolesc Med 2004; 158:1037-1042
168. Hung JH, Su IJ, Lei HY, Wang HC, Lin WC, Chang WC, Huang WY, Chang WC, Lai MD: Endoplasmic reticulum stress stimulates the expression of COX-2 through activation of NFkB and pp38 mitogen-activated protein kinases.J. Biol. Chem. 2004;279:46384-46392
169. Lu CY, Chi WK, Chang MH, Ni YH, Hsu SM, Twu SJ, Su IJ, Huang LM, Lee CY: Waning immunity to plasma Hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination. Hepatology 2004;40:1415-1420
170. Wang YF, Chou CT, Lei HY, Liu CC, Wang SM, Yan JJ, Su IJ, Wang JR, Yeh TM, Chen SH, Yu CK: A mouse model-adapted enterovirus 71 strain causes neurologic disease in mice after oral infection. J Virol 2004;78:7916-7924
171. Shih SR, Chen GW, Yang CC< Yang WZ, Liu DP, Lin ZH, Su IJ: Laboratory-based surveillance and molecular epidemiology of influenza virus in Taiwan. Journal of Clinical Microbiology 2005:43;1651-1661
172. Huang KJ, Su IJ, Theron M, Wu YC, Lai SK, Liu CC, Lei HY: An interferon-r-related cytokine storm in SARS patients. J Med Virol 2005;
173. Jou RW, Chen HY, Chiang CY, Yu MC, Su IJ: Genetic diversity of multi-resistant mycobacterium tuberculosis isolates and identification of 11 novel rpo-B alleles in Taiwan. J Clin Microbiol 2005;43:1390-1394
174. Wang HC, Chang WC, Chang WW, Huang WY, Lei HY, Lai MD, Fausto N, Su IJ: Hepatitis B virus pre-S2 mutant induced upregulation of cyclin A and nodular proliferation of hepatocytes. Hepatology 2005;41:761-770
175. Chen KT, Twu SJ, Chang HL, Wu YC, Chen CT, Lin TH, Olsen SJ, Dowell S, , Su IJ: SARS in Taiwan: an overview and the lessens learned. International Journal of Infectious Disease. 2005;9:77-85
176. Shieh WJ, Hsiao CH, Paddock CD, Guarner J, Goldsmith CS, Tatti K, Packard M, Muller L, Mu MZ, Rollin P, Su IJ, Zaki SR: Immunohistochemical, in situ hybridization, and ultrastructural localization of SARS-associated coronavirus in lung of a fatal case of SARS in Taiwan. Human Pathol 2005;36:303-309
177. Hsiao CH, Wu MZ, Chen CL, Hsueh PR, Hsieh SW, Yang PC, Su IJ: Evolution of pulmonary pathology in SARS. J Formosan Med Assoc 2005;104:75-81
178. Lin YS, Lin CF, Fang YT, Kuo YM, Liao PC, Yeh TM, Hwa KY, Hsieh CK, Yen JH< Wang HJ, Su IJ, Lei HY: Antibody to SARS-associated coronavirus spike protein domain 2 cross-reacts with lung epithelial cells and causes cytotoxicity. Clinical and Experimental Immunology 2005;141:500-508
179. Chang KC, Khen NT, Jones D, Su IJ: Epstein-Barr virus is associated with all histological subtypes of Hodgkin lymphoma in Vietnamese children. Human Pathology 2005;36:747-755
180. Cheng TL, Chang WW, Su IJ, Lai MD, Huang WY, Lei HY, Chang WT: Therapeutic inhibition of hepatitis B virus surface antigen expression by RNA interference. Biochem Biophy Research Commun 2005;336:820-830
181. Chen LT, Lin JT, Tai J, Chen GH, Yeh HZ, Yang SS, Wang SP, Kuo SS, Sheu BS, Jan CM, Wang TE, Wu CW, Chen CL, Su IJ, Whang-Peng J, Cheng AL: Long-term results of anti-Helicobacter pylori therapy in early stage gastric high grade transformed MALT lymphoma. J Natl Cancer Inst. 2005 ;97:1343-1353
182. Chuang HC, Lay JD, Chuang SE, Su IJ: Epstein-Barr virus LMP-1 inhibits the expression of XLP-SAP and upregulates TNF-alpha in T lymphocytes: Implication for the EBV-associated hemophagocytic syndrome. Blood 2005;106:3090-3096
183. Cheng TL, Chang WW, Su IJ, Lai MD, Huang WY, Lei HY, Chang WC: Therapeutic inhibition of HBV surface antigen expression by RNA interference. BBRC 2005; 336:820-830
184. Lu CC, Chen JC, Tsai ST, Jin YT, Tsai JC, Chan SH, Su IJ: Nasopharyngeal carcinoma-susceptibility locus is localized to a 132 kb segment containing HLA-A using high resolution microsatellite mapping. Int J Cancer 2005;115:742-746
185. Hsu YS, Chen CW, Sun SF, Chou RW, Lee JZ, Su IJ: Association of polymorphism and expression of NRAMP-1 gene in patients with tuberculosis in Taiwanese aborigines. J. Formosan Med Assoc. 2006;105:363-369
186. Wang HC, Huang WY, Lai MD, Su IJ: HBV pre-S mutants, ER stress, and hepatocarcinogenesis ( Review ). Cancer Science 2006;97:683-688
187. Yen MY, Lin YE, Su IJ, Huang FY, Ho MS, Chang SC, Lee CH: Using an integrated infection control strategy during outbreak control to minimize nosocomial infection of SARS among healthcare workers. J Hospital Infection. 2006;62:195-199
188. Tsai HP, Wang HC, Kiang D, Huang SW, Kuo PH, Liu CC, Su IJ, Wang JR: Increasing appearance of reassortant influenza B virus in Taiwan from 2002 to 2005. J Clin Microbiol 2006;44:2705-2713
189. Wang SM, Liu CC, Wang HC, Su IJ, Wang JR: Human metapneumovirus infection among children in Taiwan : a comparison of clinical manifestations with other virus-associated respiratory tract infections. Clin Microbiol Infect 2006;
190. Chen YT, Shu HY, Li LH, Liao TL, Wu KM, Shiau YR, Yan JJ, Su IJ, Lauderdale TL: Complete nucleotide sequence of pK245, a 98 kilobase plasmid conferring quinolone resistance and ESBL actovoty in a clinical Klebsiella pneumoniae isolate. Antimicrobial Agents and Chemotherapy. 2006;50:3861-3866
191. Lay JD, Hong CC, Huang JS, Yang YY, Pao CY, Liu CH, Lai YP, Lai GM, Cheng AL, Su IJ, Chuang SE: Sulfasalzine suppresses drug resistance and invasiveness of lung adenocarcinoma cells expressing AXL. Cancer Res. 2007;67:3878-3887
192. Wen-Chuan Hsieh, Chen CR, Lin YH, Hayashi K, Su IJ: Emergence of heterophile antibodies precipitates phagocytosis of red cells by macrophages in EBV-associated hemophagocytic syndrome. Am J Pathol 2007;70:1629-1639
193. Chuang HC, Lay JD, Chang Y, Hsieh WC, Chuang SE, and Su IJ: Survival of LMP-1-expressed T cells from TNF-alpha-induced apoptosis: A molecular mechanism for the progression of hemophagocytic syndrome to T cell lymphoma. Am J Pathol 2007;70::1607-1617
194. Hsieh YH, Su IJ, Lei HY, Lai MD, Chang WW, Huang WY: Differential endoplasmic reticulum stress signaling pathways mediated by iNOS. BBRC 2007;359:643-648
195. Chen YT, Lauderdale TL, Liao TL, Shu HY, Wu KM, Yan JJ, Su IJ, Tsai SF: Sequencing and comparative genomic analysis of pK29, a 269-Lb conjugative plasmid encoding CMY-8 and CTX-M-3 b-lactamase in Klebisiella pneumoniae.
Antimicrobial Agents and Chemotherapy 2007;51:3004-3007
196. Chuang HC, Lay JD, Hsieh WC, Su IJ: Pathogenesis and mechanism of disease progression from hemophagocytic lymphohistiocytosis to Epstein-Barr virus-associated T cell lymphoma. Cancer Science 2007;68( 9 ):1281-1288
197. Hsieh YH, Su IJ, Wang HC, Tsai JH, Huang YJ, Chang WW, Lai MD, Lei HY, Huang WY: Hepatitis B virus pre-S2 mutant surface antigen induces degradation of cyclin-dependent kinase inhibitor p27 through c-Jun activation domain-binding protein 1. Molecular Cancer Research 2007;5:1063-1072
198. Tseng FT, Huang HC, Chi CY, Liu CC, Wu HS, Su IJ ( Co-corresponding author ), Wang JR: Epidemiologic survey of enterovirus infection occurring in Taiwan between 2000-2005. J Med Virol 2007;79:1850-1860
199. Wu TC, Wang YF, Lee YP, Wang JR, Liu CC, Wang SM, Lei HY, Su IJ, Yu CK: Immunity to avirulent enterovirus 71 and coxackie A16 virus protects against enterovirus 71 infection in mice. J Virology 2007; 81:10310-10315
200. Huang SC, Hsu YW, Wang HC, Kiang D, Tsai HP, Wang SM, Liu CC, Lin KH, Su IJ, Wang JR: Appearance of intratypic recombination of EV71 in Taiwan from 2002-2005. Virus Research 2008;131:250-259
201. Wu SJ, Chen CY, Su IJ, Tang JL, Chou WC, Ko BS, Huang SY, Yao M, Tsay W, Chen YC, Wang CH, Tien HF: Clinical characteristics and treatment response of Hodgkin’s lymphoma in Taiwan. J Formosan Medical Assoc. 2008;107:4-12
202. Chang KC, Chen CT, Dan J, Su IJ: Changing patterns in the frequency of Hodgkin’s disease subtype and Epstein-Barr virus association in Taiwan. Cancer Science 2008;99:345-9
203. Chou YC, Prakash E, Huang CF, Lien TW, Chen X, Su IJ, Chao YS, Hseih HP, Hsu TA: Bioassy-guided purification and identification of PPAR a/r agonists from Chlorella sorokiniana. Phytotherapy Research 2008;DOI;10.1002/ptr
204. Lu CY, Ni YH, Chiang BL, Chen PJ, Chang MH, Chang LY, Su IJ, Kuo S, Huang LM, Chen DS, Lee CY: Humoral and cellular immune responses to a hepatitis B virus vaccine booster 15 to 18 years following neonatal immunization. J Infectious Dis. 2008;197:1419-1426
205. Hsu MC, Wu SY, Chang SS, Su IJ, Tsai CH, Lai SJ, Shiau AL, Takada K, Chang Y: Epstein-Barr virus lytic transactivator Zta enhances chemotactic activity through induction of interleukin-8 in nasopahryngeal carcinoma cells. J Vorol 2008;82:3679-3688
206. Wu TS, Shih FY, Yen MY, Wu JS, Lu SW, Chang CM, Hsiung C, Chou JH, Chu YT, Chang H, Chiu CH, Tsui FC, Wagner M, Su IJ, King CC: Establishing a nationwide emergency department-based syndromic surveillance system for better public health response in Taiwan. BMC Public Health 2008;8:18-30
207. Chang WW, Su IJ, Lai MD, Chang WT, Huang WY, Lei HY: Suppression of p38 mitogen-activated protein kinase inhibits hepatitis B virus replication in human hepatoma cells: the antiviral role of nitric oxide. J Viral Hepatitis.. 2008
208. Tu HY, Tseng FT, Lu CT, Tsai SF, Su IJ: Association of Mycobacterium tuberculosis genotypes with ethnic and migratory populations in Taiwan, Infection, Genetics, and Evolution 2008;8:353
209. Su IJ: How the SARS experience has helped preparations for future outbreaks: the Taiwan experience. Procceding of Novel and Re-emerging respiratory viral diseases at the beginning of the 21th century. Novartis Foundation Symposium, pp 91-98, 2008
210. Hsu C, Hsiung C, Su IJ, Hwang WS, Wang MC, Lin SF, Lin TH, Hsiao HH, Young JH, Chang MC, Liao YM, Li CC. Tien HF, Chao TY, Cheng AL, Chen PJ: A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin’s lymphoma: A ramdomized trial. Hepatology 2008;47:844-853
211. Su IJ: Perspectives on the pathogenesis and therapy of hemophagocytic syndrome (invited article). J Formosan Med Assoc. 2008;107:277-280
212. Chang KC, Chen SH, Jones D, Su IJ: Aberrant expression of Epstein-Barr virus LMP-1 and cyclin A in H cells, RS cells, and mummified cells of Hodgkin’s lymphoma. (Histopathology, submitted )
213. Chuang HC, Chang Y, Hsieh YC, Su IJ: EBV LMP-1 downregulates SAP/SH2D1A gene via ATF5 to activate T cells: Implication for EBV-associated hemophagocytic syndrome. (Am J Pathol, revised)
214. Yang JC, Deng CF, Wu HC, Wu LH, Su IJ: Enhanced expression of VEGF-A in ground glass hepatocytes of chronic HBV infection. (Hepatology, submitted)
215. Hsieh WC, Lan BH, Chi CY, Chuang HC, Su IJ: Efficacy of peroxisome proliferator activated receptor agonist in the control of virus-associated hemophagocytic syndrome. (Blood, submitted)
216. Chi CY, Tseng FT, ---, Su IJ: Investigation of infections by Oral Poliovirus vaccine strain in southern Taiwan 2000-2005. J Clin Virol (submitted)




 



 
 







Web Site Hit Counters
Views
 


Contact Us | Term of Use | 中文
Business Registration Number : 53171744E
2009 All Rights Reserved.